Previous Close | 31.63 |
Open | 31.57 |
Bid | 28.64 x 100 |
Ask | 28.70 x 200 |
Day's Range | 27.85 - 31.57 |
52 Week Range | 27.85 - 59.10 |
Volume | |
Avg. Volume | 663,654 |
Market Cap | 2.254B |
Beta (5Y Monthly) | 1.14 |
PE Ratio (TTM) | 34.14 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that it has rescheduled the release of the Company’s first quarter 2024 financial results to Monday, May 6, 2024. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. EDT. A live webcast will be available on the Investors section of the Company’s website at investor.integr
PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions. The addition of Acclarent's innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel. The acq
Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology MicroMatrix®Flex MicroMatrix®Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix® paste. PRINCETON, N.J., March 11, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced MicroMatrix® Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixin